The Latest Breaking News from PfizerBioNTech

Vaccination is a global strategy, yet many low-income countries can't access then, perpetuating the pandemic

Half the pancreatic cancer patients in a new clinical trial were alive and cancer free after 18 months. Most usually die within three months.

"This study is too flawed to be used to set policy on the mRNA vaccines in younger males," one expert said

What is different about the updated booster shots? Two scientists offer their expertise to answer five questions about the shots.

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a second Coronavirus booster vaccine to target the Omicron variant ahead of the autumn booster programme

The vaccine targets both the original strain of coronavirus and the Omicron variant.

On Sept. 1, 2022, the Centers for Disease Control and Prevention endorsed the use of updated COVID-19 booster shots that are specifically tailored to combat the two most prevalent omicron subvariants, BA.4 and BA.5. The decision comes just a day after the Food and Drug Administration’s emergency use authorization of…

But does everyone really need to get boosted?

Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. Pfizer shares fell nearly 1%, while BioNTech US-listed shares were down about 1.5%…